M3T01

N/A

Report date: 2024/12/06 20:00:46

Base Information

Drug NameM3T01
Drug Alias NameM3T01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionSoluble Fas ligand inhibitors
TargetsSoluble Fas ligand
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProvidence Health & Services
China Registration ClassN/A

Develop Information

Active CompaniesProvidence Health & Services
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A